Īrija - angļu - HPRA (Health Products Regulatory Authority)

glob limited - mirtazapine - film coated tablet - 45 milligram

Īrija - angļu - HPRA (Health Products Regulatory Authority)

glob limited - mirtazapine - film coated tablet - 30 milligram

Īrija - angļu - HPRA (Health Products Regulatory Authority)

primegen limited - alimemazine tartrate - film-coated tablets - 10mg - phenothiazine derivatives - it has powerful antihistamine and anti-emetic actions and is used in the management of urticaria and pruritus. it may be used in pre-medication as a sedative before anaesthesia in children aged between 2 to 7 years

Īrija - angļu - HPRA (Health Products Regulatory Authority)

primegen limited - alimemazine tartrate - syrup. - 1.5mg - phenothiazine derivatives - it has powerful antihistamine and anti-emetic actions and is used in the management of urticaria and pruritus. it may be used in pre-medication as a sedative before anaesthesia in children aged between 2 to 7 years

Īrija - angļu - HPRA (Health Products Regulatory Authority)

primegen limited - alimemazine tartrate - syrup - 6mg - phenothiazine derivatives - it has powerful antihistamine and anti-emetic actions and is used in the management of urticaria and pruritus. it may be used in pre-medication as a sedative before anaesthesia in children aged between 2 to 7 years

Īrija - angļu - HPRA (Health Products Regulatory Authority)

primegen limited - lymecycline - capsule, hard - 408mg - tetracyclines - it is indicated for the treatment of moderate to severe acne vulgaris

Īrija - angļu - HPRA (Health Products Regulatory Authority)

primegen limited - trazodone hydrochloride - oral solution - 50mg/5ml - other antidepressants - relief of symptoms in all types of depression including depression accompanied by anxiety. symptoms of depression likely to respond in the first week of treatment include depressed mood, insomnia, anxiety, somatic symptoms and hypochondriasis.

Eiropas Savienība - angļu - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - atosiban (as acetate) - premature birth - other gynecologicals - atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds’ duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.

Eiropas Savienība - angļu - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - levetiracetam - epilepsy - other antiepileptics - levetiracetam sun is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam sun is indicated as adjunctive therapy:in the treatment of partial-onset seizures with or without secondary generalisation in adults and children from four years of age with epilepsy;in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy;in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.levetiracetam sun concentrate is an alternative for patients when oral administration is temporarily not feasible.

Eiropas Savienība - angļu - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - temozolomide - glioma; glioblastoma - antineoplastic agents - temozolomide sun is indicated for the treatment of:adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy (rt) and subsequently as monotherapy treatment;children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.